Arcutis Biotherapeutics, Inc. (ARQT)

26.04 +0.62 (+2.46%) USD  |  NASDAQ  |  Feb 23, 10:06
More

Arcutis Biotherapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Pacira Biosciences, Inc. Upgrade